INTERNATIONAL PATENT: BIONTECH SE, ONCOC4, INC., MSD INTERNATIONAL GMBH FILES APPLICATION FOR "COMBINATION THERAPY COMPRISING ANTI-CTLA4 ANTIBODIES AND ANTI-PD-1 ANTIBODIES FOR PLATINUM-RESISTANT OVARIAN CANCER TREATMENT"

GENEVA, March 23 -- BIONTECH SE (An der Goldgrube 1255131 Mainz), ONCOC4, INC. (9640 Medical Center DriveRockville, Maryland 20850), MSD INTERNATIONAL GMBH (Tribschenstrasse 606005 Luzern) filed a patent application (PCT/EP2025/075952) for "COMBINATION THERAPY COMPRISING ANTI-CTLA4 ANTIBODIES AND ANTI-PD-1 ANTIBODIES FOR PLATINUM-RESISTANT OVARIAN CANCER TREATMENT" on Sep 11, 2025. With publication no. WO/2026/057739, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LIU, Yang (11516 Luvie CourtPotomac, Maryland 20854), ZHE...